Get started
Author

Oluwademilade Nuga

Observed names: Nuga, Oluwademilade, O. Nuga
ORCID: 0000-0003-4266-0931
Observed ORCID: 0000-0003-4266-0931
OpenAlex ID: A5082987199
Impact of developmental state, p53 status, and interferon signaling on glioblastoma cell response to radiation and temozolomide treatment
2025 · Artem Berezovsky, Oluwademilade Nuga, et al. · PLoS ONE · 6
PDF
Insights into dentatorubral-pallidoluysian atrophy from a new Drosophila model of disease
2025 · Matthew V. Prifti, Oluwademilade Nuga, et al. · Neurobiology of Disease · 5
Linear poly-ubiquitin remodels the proteome and influences hundreds of regulators in Drosophila
2024 · Oluwademilade Nuga, Kristin Richardson, et al. · G3 Genes Genomes Genetics · 2
Disrupted Transcriptional Networks by Mutant Atrophin-1 in a Cell Culture Model of Dentatorubral-Pallidoluysian Atrophy
2025 · Oluwademilade Nuga, Masoumeh Pourhadi, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Linear ubiquitin chains remodel the proteome and influence the levels of hundreds of regulators in Drosophila
2024 · Oluwademilade Nuga, Kristin Richardson, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
Impact of genomic background and developmental state on signaling pathways and response to therapy in glioblastoma patient-derived cells
2024 · Artem Berezovsky, Oluwademilade Nuga, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Abstract 2519: Identification of novel MET fusion transcript amplification in glioblastoma
2018 · Oluwademilade Nuga, Ana deCarvalho, et al. · Cancer Research · 1
Disrupted Transcriptional Networks in Mammalian Cells Stably Over‐Expressing Pathogenic Atrophin‐1
2025 · Oluwademilade Nuga, Masoumeh Pourhadi, et al. · Journal of Neuroscience Research
PDF
EXTH-73. Identifying therapeutic targets for recurrent glioblastoma using patient-derived longitudinal models
2025 · Indrani Datta, Oluwademilade Nuga, et al. · Neuro-Oncology
Author response for "Disrupted transcriptional networks in mammalian cells stably over-expressing pathogenic Atrophin-1"
2025 · Oluwademilade Nuga, Masoumeh Pourhadi, et al.
Author response for "Disrupted transcriptional networks in mammalian cells stably over-expressing pathogenic Atrophin-1"
2025 · Oluwademilade Nuga, Masoumeh Pourhadi, et al.
45 (PB033): Assessing the predictive value of genomic drivers for targeted therapy in glioblastoma: Insights from a pre-clinical platform
2024 · A. Decarvalho, O. Nuga, et al. · European Journal of Cancer
Exth-06. Glioblastoma Patient Specific Transcriptome Remodeling in Response to Mdm2 Antagonist Treatment of Wild-type P53 Cancer Stem Cells Is Associated With Sensitivity and Strategies for Combination Therapy
2023 · Yuling Meng, Nouman Mughal, et al. · Neuro-Oncology
PDF
Cyclin Dependent Kinase 4/6 as a Therapeutic Target in the Treatment of Glioblastoma
2023 · Nuga, Oluwademilade · Human Biology
Exth-36. Pharmaceutical Inhibition of Cyclin Dependent Kinase 4/6 (cdk4/6) in Glioblastoma
2020 · Oluwademilade Nuga, Yuling Meng, et al. · Neuro-Oncology
PDF
Gene-55. Gene Expression Signature Associated With Aggressive Glioblastoma Growth Is Enriched in Chromatin Modification and Stemness Transcriptional Regulation Programs
2019 · Artem Berezovsky, Oluwademilade Nuga, et al. · Neuro-Oncology
PDF
Abstract 4742: The influence of cellular developmental state on response to therapeutics in glioblastoma
2019 · Oluwademilade Nuga, Ana deCarvalho, et al. · Cancer Research
Abstract 4742: The influence of cellular developmental state on response to therapeutics in glioblastoma
2019 · Oluwademilade Nuga, Ana deCarvalho, et al. · Experimental and Molecular Therapeutics
Identification of novel MET fusion transcript amplification in glioblastoma
2018 · Oluwademilade Nuga, Ana Carolina de Carvalho, et al.
Works count: 19
Citation count: 17
H-index: 2
I10-index:
Year
Topic
Type